Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $3.59 Million - $7.68 Million
-100,692 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$57.56 - $82.54 $412,993 - $592,224
-7,175 Reduced 6.65%
100,692 $7.04 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $3.15 Million - $4.38 Million
43,469 Added 67.5%
107,867 $8.4 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $1.95 Million - $2.69 Million
21,646 Added 50.63%
64,398 $6.15 Million
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $1.36 Million - $1.81 Million
-11,665 Reduced 21.44%
42,752 $5.63 Million
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $1.85 Million - $2.64 Million
-18,599 Reduced 25.47%
54,417 $7.21 Million
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $3.13 Million - $4.38 Million
42,942 Added 142.79%
73,016 $7.44 Million
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $1.06 Million - $1.76 Million
-19,016 Reduced 38.74%
30,074 $2.62 Million
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $649,454 - $1.79 Million
17,136 Added 53.63%
49,090 $2.85 Million
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $3.28 Million - $4.22 Million
-42,273 Reduced 56.95%
31,954 $2.96 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $2.42 Million - $3.28 Million
-26,769 Reduced 26.51%
74,227 $6.71 Million
Q2 2019

Aug 13, 2019

SELL
$89.51 - $118.04 $83,602 - $110,249
-934 Reduced 0.92%
100,996 $11.9 Million
Q1 2019

May 09, 2019

SELL
$61.98 - $96.5 $3.36 Million - $5.23 Million
-54,210 Reduced 34.72%
101,930 $8.83 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $1.98 Million - $2.93 Million
-35,421 Reduced 18.49%
156,140 $9.85 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $4.67 Million - $7.79 Million
96,631 Added 101.79%
191,561 $15.1 Million
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $3.59 Million - $6.64 Million
94,930 New
94,930 $5.68 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Riverpark Capital Management LLC Portfolio

Follow Riverpark Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverpark Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverpark Capital Management LLC with notifications on news.